ATR Stock - AptarGroup, Inc.
Unlock GoAI Insights for ATR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.58B | $3.49B | $3.32B | $3.23B | $2.93B |
| Gross Profit | $1.36B | $1.26B | $1.16B | $1.16B | $1.09B |
| Gross Margin | 37.8% | 36.2% | 35.0% | 35.8% | 37.1% |
| Operating Income | $496.50M | $404.02M | $379.27M | $347.35M | $339.50M |
| Net Income | $374.54M | $284.49M | $239.29M | $244.10M | $214.04M |
| Net Margin | 10.5% | 8.2% | 7.2% | 7.6% | 7.3% |
| EPS | $5.65 | $4.34 | $3.66 | $3.72 | $3.32 |
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 3rd 2025 | William Blair | Downgrade | Market Perform | - |
| September 4th 2025 | KeyBanc Capital Markets | Initiation | Overweight | $220 |
| January 7th 2025 | Raymond James | Initiation | Outperform | $200 |
| January 6th 2025 | BofA Securities | Downgrade | Neutral | $173 |
| October 14th 2024 | Jefferies | Upgrade | Buy | $215← $155 |
| April 29th 2024 | William Blair | Upgrade | Outperform | - |
| January 3rd 2024 | Robert W. Baird | Upgrade | Outperform | $150← $125 |
Earnings History & Surprises
ATREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | $1.29 | — | — | — |
Q4 2025 | Oct 30, 2025 | $1.57 | $1.62 | +3.2% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $1.58 | $1.66 | +5.1% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $1.16 | $1.20 | +3.4% | ✓ BEAT |
Q1 2025 | Feb 6, 2025 | $1.28 | $1.52 | +18.8% | ✓ BEAT |
Q4 2024 | Oct 24, 2024 | $1.42 | $1.49 | +4.9% | ✓ BEAT |
Q3 2024 | Jul 25, 2024 | $1.36 | $1.37 | +0.7% | ✓ BEAT |
Q2 2024 | Apr 25, 2024 | $1.15 | $1.26 | +9.6% | ✓ BEAT |
Q1 2024 | Feb 8, 2024 | $1.12 | $1.21 | +8.0% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $1.27 | $1.39 | +9.4% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $1.14 | $1.23 | +7.9% | ✓ BEAT |
Q2 2023 | Apr 27, 2023 | $0.90 | $0.95 | +5.6% | ✓ BEAT |
Q1 2023 | Feb 16, 2023 | $0.79 | $0.92 | +16.5% | ✓ BEAT |
Q4 2022 | Oct 27, 2022 | $0.94 | $0.95 | +1.1% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $0.96 | $0.96 | 0.0% | = MET |
Q2 2022 | Apr 28, 2022 | $0.96 | $0.96 | 0.0% | = MET |
Q1 2022 | Feb 17, 2022 | $0.91 | $0.93 | +2.2% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.94 | $0.94 | 0.0% | = MET |
Q3 2021 | Jul 29, 2021 | $0.97 | $0.91 | -6.2% | ✗ MISS |
Latest News
AptarGroup Announces That Its Bidose Liquid Nasal Spray System Liquid Is The Mechanism For Delivering The Newly Approved CARDAMYST
📈 PositiveAptarGroup Acquires Brazilian Pharma Packaging Specialist Sommaplast; No Financial Terms Disclosed
📈 PositiveWells Fargo Maintains Overweight on AptarGroup, Lowers Price Target to $133
➖ NeutralBaird Maintains Outperform on AptarGroup, Lowers Price Target to $145
➖ NeutralAptarGroup shares are trading lower after the company reported Q3 financial results and issued Q4 adjusted EPS guidance below estimates.
📉 NegativeAptarGroup Sees Q4 Adj EPS $1.20-$1.28 vs $1.43 Est
📉 NegativeAptarGroup Q3 Adj. EPS $1.62 Beats $1.57 Estimate, Sales $961.131M Beat $953.508M Estimate
📈 PositiveAptar Digital Health Announces FDA Has Granted 510(K) Clearance For HeroTracker Sense
📈 PositiveAptarGroup Increases Its Quarterly Dividend From $0.45 To $0.48
📈 PositiveKeybanc Initiates Coverage On AptarGroup with Overweight Rating, Announces Price Target of $220
📈 PositiveFrequently Asked Questions about ATR
What is ATR's current stock price?
What is the analyst price target for ATR?
What sector is AptarGroup, Inc. in?
What is ATR's market cap?
Does ATR pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ATR for comparison